Leukemia, Eosinophilic, Acute clinical trials

The registry lists 59 studies for Leukemia, Eosinophilic, Acute across more than 10 countries. 0 are recruiting or about to start. 2 of them are mainly about Leukemia, Eosinophilic, Acute (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-21.

Status

Completed: 46
Terminated: 7
Status unknown: 5
Active, not recruiting: 1

Phase

Phase 1: 23
Phase 2: 20
Phase 3: 8
Phase 4: 1

Where

United States: 45
Canada: 8
Italy: 4
France: 3
United Kingdom: 3
Belgium: 3

Who runs them

National Cancer Institute (NCI) (20) · Children's Oncology Group (5) · SWOG Cancer Research Network (4) · Alliance for Clinical Trials in Oncology (3) · Fred Hutchinson Cancer Center (3) · Roswell Park Cancer Institute (2) · European Organisation for Research and Treatment of Cancer - EORTC (2) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (2)

What is being tested here

Drugs under test in Leukemia, Eosinophilic, Acute studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Phase 3	All
Cytarabine	2	13
Gemtuzumab	4	5
Tipifarnib	1	5
Etoposide	2	4
Daunorubicin	2	4
Clofarabine	0	4
Idarubicin	0	4
Eltrombopag	0	2
Busulfan	1	2
Imatinib	0	2

Drug classes tested here Antimetabolites 18 · Alkylating agents 4 · Tyrosine kinase inhibitors (TKIs) 4

Who these studies take

No Leukemia, Eosinophilic, Acute study is recruiting now.

Across all 59 studies, recruiting or not: 41% stop at 75 or younger and 36% at 65; 37% take children; 2% are for women only and 0% for men only; 0% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 50 of 59. Browse all 59 → or search them.